Navigation Links
The Partnership at Drugfree.org Comments on FDA Approval of Alkermes Opioid Dependence Medication
Date:10/13/2010

NEW YORK, Oct. 13 /PRNewswire-USNewswire/ --  The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and all those who are struggling to overcome opioid addiction.  Addiction, a disease of the human brain, is a chronic illness while opioid dependence is frequently characterized by relapse.  

"Opioid dependence, whether from misuse of prescription pain medications or illicit use of heroin, is one of the most imperative health issues facing our nation, and as an organization, we have devoted significant resources to help families find appropriate treatment for a loved one with an addiction and support that person in recovery," said Steve Pasierb, President and Chief Executive Officer of The Partnership at Drugfree.org.  "This new indication for Alkermes' product as a non-addictive approach to prevent relapse to opioid dependence in people age 18 and older brings hope to the families we serve.  Our view is that this medication must be used in concert with appropriate addiction treatment services and psychosocial support."

Parents are at the center of the organization's mission, and The Partnership at Drugfree.org recently unveiled a new name and expanded resources, providing them with answers and support at whatever their stage of need, from prevention to recovery.  Among these new offerings are dedicated treatment resources on drugfree.org, and specifically, Time To Get Help, a comprehensive tool that includes information on how to obtain a proper assessment, identify and pay for appropriate treatment and connect with other parents who have had their own family experiences with substance abuse and addiction.

Recognizing that 11 million American adolescents and young adults, ages 12-29, need help with drug and alcohol problems and almost 23 million people in the U.S., age 12 or older, are struggling with substance abuse,(1) The Partnership at Drugfree.org worked with parents and experts in the field of substance abuse, treatment and recovery to create Time To Get Help. This new treatment resource and community helps parents and caregivers gain a better understanding of teen alcohol and drug abuse, dependence and addiction; get support from experts and other parents who have been there and understand the challenges and emotions of caring for an addicted child; and find the right treatment for their child and family.

Visit drugfree.org to learn more about various programs and resources on prevention, intervention, treatment, recovery and community education from The Partnership at Drugfree.org. 

The Partnership at Drugfree.org is a nonprofit organization that helps parents prevent, intervene in and find treatment for drug and alcohol use by their children.  Bringing together renowned scientists, parent experts, and communications professionals, this public health nonprofit translates current research on parenting, teen behavior, addiction and treatment into easy to understand resources at drugfree.org. Through its PACT360 nationwide Community Education Program, the nonprofit educates and mobilizes local community efforts to address drug threats at the grassroots level, including methamphetamine and prescription drug abuse, and also provides parent training and teen programs that help prevent teen substance abuse.  The organization depends on donations from individuals, corporations, foundations and government and is thankful to SAG/AFTRA and the advertising and media industries for their ongoing generosity.

(1) 2009 National Survey on Drug Use and Health,  SAMHSA  


'/>"/>
SOURCE The Partnership at Drugfree.org
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Creating Partnerships Across R&D and Marketing to Ensure a Successful Global Launch
2. MedInformatix, PhoneTree Integrate Health Practice Products Via New Partnership
3. Physicians Interactive Launches Partnership with SampleMD to Expand Sampling Options for Clinicians and Reduce Costs for Patients
4. Objet Geometries and Javelin Technologies Form Strategic Distribution Partnership for 3D Printers
5. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
6. VasoNova Inc. Announces Strategic Partnership With Navilyst Medical Inc.
7. HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada
8. CVS Caremark Presents Ongoing Behavioral Change Research Partnership Research to the Pittsburgh Business Group on Health
9. NuGEN Joins AMDeCs Vendor Partnership Program
10. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
11. HUYA Biosciences Establishes Strategic Partnership with Sun Yat-sen Universitys School of Pharmaceutical Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)... -- Sickle cell disease (SCD) is an inherited chronic ... get stuck in veins and block blood flow, which ... leading to death. Each year, approximately 300,000 people around ... them lack access to comprehensive care or effective treatment ... SCD, a pill called hydroxyurea approved more than a ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology:
(Date:12/4/2016)... NY (PRWEB) , ... December 03, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted its first Swirl: A Wine Tasting Event in New York City, ...
(Date:12/4/2016)... ... December 03, 2016 , ... Houston ... the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine ... Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... ... undergoing major cosmetic surgery can now take advantage of a cosmetic procedure known ... skin rejuvenation treatment that reduces the appearance of age spots, fine lines, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with ... preventative dental services to more than 15,900 children 5 years old and younger and ... $38 million over a span of five years to Western University of Health Sciences, ...
(Date:12/2/2016)... ... 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host the ... the 2016 MPN Heroes—eight individuals who have made a difference in the field of ... standard of care, demonstrating leadership within the MPN community and/or a commitment to individual ...
Breaking Medicine News(10 mins):